CHGN 111
Alternative Names: CHGN111Latest Information Update: 18 Sep 2015
At a glance
- Originator Chronogen
- Class
- Mechanism of Action Clk dual-specificity kinase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Photodamage
Most Recent Events
- 18 Sep 2015 Discontinued - Preclinical for Photodamage in Canada (Topical)
- 01 May 2006 Preclinical trials in Photodamage prevention in Canada (Topical)